Tag: Prometic

April 3, 2018

Markets Struggle to Stay Afloat

Morning Market Breakdown, April 3: After a Monday filled with losses, the major indexes continued to flounder going into Tuesday...
February 5, 2018

5 Pharmaceutical Stocks on the TSX and TSXV

Opportunities abound when it comes to TSX pharmaceutical stocks, particularly those of the nano or micro cap variety, we're profiling...
December 13, 2017

5 Top Pharmaceutical Stories of 2017

Here are the five top stories that caught the attention of our investor audience in the pharmaceutical business during 2017.
December 11, 2017

Prometic's Candidate Gets Promising Innovative Medicine Designation in the UK

Prometic Life Sciences announced PBI-4050, its orally-active drug candidate PBI-4050, received a Promising Innovative Medicine designation by the UK Medicines...
December 1, 2017

Prometic Closes Credit Line With Structured Alpha LP

Prometic Life Sciences announced it closed an $80 million line of credit with Structured Alpha LP.
November 22, 2017

Prometic Posts Interim Clinical Data from Ongoing Phase 3 Trial

Prometic Life Sciences shared new interim data from six-month clinical data from its ongoing pivotal IVIG Phase 3 clinical trial...
October 26, 2017

Prometic Gets Trial Clearance from Swedish Medical Products Agency

Prometic Life Sciences announced it received approval for a phase 2 clinical trial by the Swedish Medical Products Agency.